Obstetrics & Gynecology · Philadelphia, PA
NPI
1801117205
Since 2010
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
111 S 11th St
Philadelphia, PA, 19107
Phone (215) 955-6610
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,159
58 services
Medicare patients, 2024
51
Average age 69
Drug cost, 2024
$11K
144 prescriptions
Company payments, 2025
$18.66
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Danielle B Cullen was code G0101 (cervical or vaginal cancer screening; pelvic and clinical breast examination), 27 times for 27 patients. In total Danielle B Cullen billed 58 services in 7 codes, and Medicare paid $2,159.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-02-07.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 27 | 27 | $28.00 | $756 |
By year: 2022 $1,559 for 40 services; 2023 $2,388 for 50 services; 2024 $2,159 for 58 services.
Medicare prescription drug claims, 2024
In 2024, the drug Danielle B Cullen prescribed most often to Medicare patients was Estradiol, with 28 prescriptions and refills. In total Danielle B Cullen wrote 144 Medicare prescriptions that cost $11K.
Brand drugs: 17 claims; generic drugs: 127 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Danielle B Cullen $18.66 ($18.66 in general payments such as food, travel and fees) from 1 company. The largest payer was Sumitomo Pharma America, Inc. with $18.66.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 1 | $18.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.